1005 Alcyon Dr Bellmawr NJ 08031
+1 484-446-2566
support@bmcpros.com
MIT and Mass Brigham (MGB) leverage the advantages of two world-class research institutions recently celebrated the launch of the MIT-MGB seed program. A new program supported by Analog Devices Inc. (ADI) will fund a joint research project led by researchers at MIT and Mass Brigham. These collaborative projects will advance research on human health with the aim of developing next-generation therapies, diagnostics and digital tools that can improve lives at scale.
The program represents a unique opportunity to greatly accelerate innovation to address some of the most pressing challenges in human health. By supporting MIT and BYU’s interdisciplinary teams, including researchers and clinicians, the Seed Program will foster groundbreaking work that brings together expertise in artificial intelligence, machine learning, and measurement and induction technology with pioneering clinical research and patient care.
“The power of the program is that it combines MIT’s strengths in science, engineering and innovation with large-scale Brigham Young’s world-class scientific and clinical research. With support and motivation to work together, researchers and clinicians will have the freedom to solve compelling problems and find novel ways to overcome their approaches to patient care,” said Sally Kornbluth, Sally Kornbluth, Sally Kornbluth, Sally Kornbluth, Sally Kornbluth, Sally Kornbluth, Sally Kornbluth, Sally Kornbluth, Sally Kornbluth, Sally Kornbluth, Sally Kornbluth.
“The MIT-MGB Seed Program will enable interdisciplinary collaboration to advance transformative research and breakthrough science. By combining the collective strengths and expertise of our great institutions, we can quickly transform healthcare, driving innovation and discovery.”
The program is funded by gifts from ADI. Over the next three years, the ADI Health and Life Science Foundation will support approximately six joint projects each year, funding allocations between the two institutions.
“The convergence of biology, medicine and computing promises to be a new era of healthcare efficacy, efficiency and access. ADI enjoys a long and fruitful history of working with MIT and Mass General Brigham, and this new initiative is exciting to us with the potential of transforming the future of patient care.”
In addition to funding, the teams selected for the program can also access entrepreneur workshops, including some hosted by the Engine – a venture capital firm focused on hard-core technology. These meetings will connect researchers with company founders, investors and industry leaders to help them map the path from lab breakthrough discoveries to real-world impacts.
The program will open proposals to researchers at MIT and BYU. The first funding project is expected to be launched in the fall of 2025. The winners will be selected by a joint review committee composed of MIT and Mass General Brigham experts.
According to Alex K. Shalek, director of the MIT MIT-MGB seed program, a collaborative research team with leaders from both institutions may help fill key gaps that often hinder health and life science innovation. Shalek also serves as Professor JW Kieckhefer of the Institute of Medical Engineering and Science (IMES), IMES and Chemistry, and an external member of the Koch Institute for Comprehensive Cancer.
“Clinicians often see that current interventions are inadequate, but may lack the scientific tools or engineering expertise needed to develop new interventions. Instead, MIT researchers may not be able to fully grasp these clinical challenges and may not have access to the right patient data and samples.” “By supporting bilateral collaboration and building communities across disciplines, the program is expected to drive key advances in diagnostic, therapeutic and AI-driven health applications.”
Emery Brown, an anesthesiologist at Massachusetts General Hospital, will join Shalek as a massive Mass Brigham faculty member for the program.
“The MIT-MGB Seed Project creates a perfect storm. The program will bring novel science and engineering to MIT faculty to attack and solve important clinical problems,” Brown added. “The solutions to important and challenging clinical problems by large-scale poplar physicians and scientists will undoubtedly inspire MIT scientists and engineers to develop new technologies, or find novel applications of existing technologies.”
The MIT-MGB Seed Program is the flagship program of the MIT Collaboration of Health and Life Sciences (MIT HEALS). It reflects the core mission of MIT HEALS to build MIT as a central hub for innovation and translation in health and life sciences and to leverage links with other world-class research institutions in the Boston area.
“The program embodies the power of interdisciplinary research,” said Anantha Chandrakasan, Chief Innovation and Strategy Officer, Dean of Engineering, and Director of Heals at MIT. “It creates a critical bridge between clinical practice and technological innovation, both areas that must be deeply connected to advance real-world solutions.”
The launch of the program was celebrated at a special event held at MIT’s Samberg Convention Center on March 31.